Perioperative management of patients with chronic kidney disease or ESRD

Best Practice and Research: Clinical Anaesthesiology

Volumn 18, Issue 1, 2004, Pages 129-144

  Palevsky, Paul M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Anaesthesia; Chronic kidney disease; Dialysis; End stage renal disease; Haemodialysis; Hyperkalaemia; Neuromuscular blocking agents; Opioid analgesics; Peritoneal dialysis; Post operative complications; Water electrolyte imbalance

Indexed keywords

ALUMINUM HYDROXIDE; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTACID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BICARBONATE; CALCIUM; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN A; DESMOPRESSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; HEPARIN; INSULIN; LABETALOL; LOOP DIURETIC AGENT; MINERAL; NONSTEROID ANTIINFLAMMATORY AGENT; POLYSTYRENESULFONATE SODIUM; POTASSIUM; RECOMBINANT ERYTHROPOIETIN; SORBITOL; SPIRONOLACTONE; SUXAMETHONIUM; TACROLIMUS; TRIAMTERENE; TRIMETHOPRIM; UNINDEXED DRUG;

ACID BASE BALANCE; ANEMIA; BLEEDING TENDENCY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG CLEARANCE; ELECTROLYTE BALANCE; FLUID BALANCE; GLOMERULUS FILTRATION RATE; HEMATOLOGIC DISEASE; HEMODIALYSIS; HOMEOSTASIS; HUMAN; HYPERCALCEMIA; HYPERKALEMIA; HYPERMAGNESEMIA; HYPERPHOSPHATEMIA; HYPERTENSION; HYPOCALCEMIA; KIDNEY DYSFUNCTION; KIDNEY FAILURE; METABOLIC ACIDOSIS; PERIOPERATIVE PERIOD; PERITONEAL DIALYSIS; POTASSIUM BALANCE; PRIORITY JOURNAL; REVIEW; ACUTE KIDNEY FAILURE; CHRONIC KIDNEY FAILURE; PEROPERATIVE CARE;

HOMEOSTASIS; HUMANS; INTRAOPERATIVE CARE; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC;

EID: 2142644542     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2003.08.003     Document Type: Article

References (74)

1. National Kidney Foundation K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification American Journal of Kidney Diseases 39 supplement 1 2002 S1-S266
2. Cockroft D.W. Gault M.H. Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31-41
3. Levey A.S. Bosch J.P. Lewis J.B. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Annals of Internal Medicine 130 1999 461-470
4. Levey A.S. Greene T. Kuseck J.W. Beck G.L. A simplified equation to predict glomerular filtration rate from serum creatinine Journal of the American Society of Nephrology 11 2000
5. U.S. Renal Data System 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health. National Institute of Diabetes, Digestive and Kidney Diseases, 2002.
6. Wallia R. Greenberg A. Piraino B. et al. Serum electrolyte patterns in endstage renal disease American Journal of Kidney Diseases 8 1986 98-104
7. Mitch W.E. Wilcox C.S. Disorders of body fluids, sodium and potassium in chronic renal failure American Journal of Medicine 72 1982 536-550
8. Greenberg A. Palevsky P.M. Disturbances in fluid, electrolyte, and acid-base balance: Part 1-Patients with chronic renal failure In Massry S.G. Glassock R.J. (Eds.) The Textbook of Nephrology 4th edn 2001 1381-1387 Lippincott Williams and Wilkins Philadelphia
9. Tuso P.J. Nissenson A.R. Danovitch G.M. Electrolyte disorders in chronic renal failure In Narins R.G. (Ed.) Clinical Disorders of Fluid and Electrolyte Metabolism 5th edn 1994 1195-1211 McGraw Hill New York
10. Komers R. Meyer T.W. Anderson S. Pathophysiology and nephron adaptation in chronic renal failure In Schrier R.W. (Ed.) Diseases of the Kidney and Urinary Tract 7th edn 2001 2689-2718 Lippencott Williams and Wilkins Philadelphia
11. Fernandez P.C. Weisberg L.S. Palevsky P.M. Physiological basis for the use of sequential nephron blockade in patients with resistant edema Puschett J.B. Greenberg A. Diuretics II: Chemistry, Pharmacology and Clinical Applications 1987 301-307 Elsevier New York
12. Palevsky P.M. Bhagrath R. Greenberg A. Hypernatremia in hospitalized patients Annals of Internal Medicine 124 1996 197-203
13. Weisberg L.S. Szerlip H.M. Cox M. Disorders of potassium homeostasis in critically ill patients Critical Care Clinics 5 1987 835-854
14. Williams M.E. Rosa R.M. Hyperkalemia. Disorders of internal and external potassium balance Journal of Intensive Care Medicine 3 1988 52-64
15. DeFronzo R.A. Cooke R. Goldberg M. et al. Impaired renal tubular potassium secretion in systemic lupus erythematosus Annals of Internal Medicine 86 1977 268-271
16. DeFronzo R.A. Taufield P.A. Black H. et al. Impaired renal tubular potassium secretion in sickle cell disease Annals of Internal Medicine 90 1979 310-316
17. Batlle D.C. Arruda J.A.L. Kurtzman N.A. Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy New England Journal of Medicine 304 1981 373-380
18. Perez G.O. Pelleya R. Oster J.R. Renal tubular hyperkalemia American Journal of Nephrology 2 1982 109-114
19. DeFronzo R.A. Goldberg M. Cook C.R. et al. Investigations into the mechanisms of hyperkalemia following renal transplantation Kidney International 11 1977 357-365
20. DeFronzo R.A. Hyperkalemia and hyporeninemic hypoaldosteronism Kidney International 17 1980 118-134
21. Lee F.O. Quismorio F.P. Troum O.M. et al. Mechanisms of hyperkalemia in systemic lupus erythematosus Archives of Internal Medicine 148 1988 397-401
22. Kalin M.F. Poretsky L. Seres D.S. Zumoff B. Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome American Journal of Medicine 82 1987 1035-1038
23. Oster J.R. Singer I. Fishman L.M. Heparin-induced aldosterone suppression and hyperkalemia American Journal of Medicine 98 1995 575-586
24. Palevsky P.M. Singer I. Disorders of potassium metabolism In Wolfson A.B. (Ed.) Endocrine and Metabolic Emergencies 1990 17-44 Churchill Livingstone New York
25. Choi M.J. Fernandez P.C. Coupaye-Gerard B. et al. Trimethoprim-induced hyperkalemia in a patient with AIDS New England Journal of Medicine 328 1993 703-706
26. Kame K.S. Ethier J.H. Quaggin S. et al. Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporin Journal of the American Society of Nephrology 2 1991 1279-1284
27. Rokaw M.D. West M.E. Palevsky P.M. Johnson J.P. FK-506 and rapamycin but not cyclosporin inhibit aldosterone-stimulated sodium transport in A6 cells American Journal of Physiology 271 1996 C194-C202
28. Hamad A. Salameh M. Zihlif M. et al. Life-threatening hyperkalemia after intravenous labetalol injection for hypertensive emergency in a hemodialysis patient American Journal of Nephrology 21 2001 241-244
29. McCauley J. Murray J. Jordan M. et al. Labetalol-induced hyperkalemia in renal transplant recipients American Journal of Nephrology 22 2002 347-351
30. Koide M. Waud B.E. Serum potassium concentrations after succinylcholine in patients with renal failure Anesthesiology 36 1972 142-145
31. Thapa S. Brull S.J. Succinylcholine-induced hyperkalemia in patients with renal failure: an old question revisited Anesthesia and Analgesia 91 2000 237-241
32. Yentis S.M. Suxamethonium and hyperkalaemia Anaesthesia and Intensive Care 18 1990 92-101
33. Greenberg A. Hyperkalemia: treatment options Seminars in Nephrology 18 1998 46-57
34. Blumberg A. Weidmann P. Shaw S. Gnadinger M. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure American Journal of Medicine 85 1988 507-512
35. Blumberg A. Weidmann P. Ferrari P. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure Kidney International 41 1992 369-374
36. Cohen R.M. Feldman G.M. Fernandez P.C. The balance of acid, base and charge in health and disease Kidney International 52 1997 287-293
37. Slatopolsky E. Hruska K. Disorders of phosphorus, calcium and magnesium metabolism In Schrier R.W. (Ed.) Diseases of the Kidney and Urinary Tract 7th edn 2001 2607-2660 Lippencott Williams and Wilkins Philadelphia
38. Biberstein M. Parker B.A. Enema-induced hyperphosphatemia American Journal of Medicine 79 1985 645-646
39. Eschbach J.W. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin Kidney International 35 1989 134-148
40. Eschbach J.W. Kelly M.R. Haley N.R. et al. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin New England Journal of Medicine 321 1989 158-163
41. Maxwell A.P. Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure Kidney International 62 2002 720-729
42. Muirhead N. Hodsman A.B. Occult infection and resistance of anaemia to rHuEpo therapy in renal failure Nephrology Dialysis and Transplantation 5 1990 232-234
43. Anderson R.J. O'Brien M. MaWhinney S. et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery Kidney International 55 1999 1057-1062
44. O'Brien M.M. Gonzales R. Shroyer A.L. et al. Modest serum creatinine elevation affects adverse outcome after general surgery Kidney International 62 2002 585-592
45. O'Hare A.M. Feinglass J. Sidawy A.N. et al. Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the Department of Veterans Affairs' National Surgical Quality Improvement Program Journal of the American Society of Nephrology 14 2003 1287-1295
46. Rabelink T.J. Zwaginga J.J. Koomans H.A. Sixma J.J. Thrombosis and hemostasis in renal disease Kidney International 46 1994 287-296
47. Livio M. Marchesi D. Remuzzi G. et al. Uraemic bleeding: role of anemia and beneficial effect of red cell transfusions Lancet 6 1982 1013-1015
48. Steiner R. Coggins C. Carvalho A. Bleeding time in uremia: a useful test to assess clinical bleeding American Journal of Hematology 7 1979 107-117
49. Lindsay R.M. Friesen M. Araonstam A. et al. Improvement in platelet function by increased frequency of haemodialysis Clinical Nephrology 10 1978 67-70
50. Mannucci P.M. Remuzzi G. Pusineri F. et al. Deamino-8-d-arginine vasopressin shortens the bleeding time in uremia New England Journal of Medicine 308 1983 8-12
51. Vigano G. Gaspari F. Locatelli M. et al. Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia Kidney International 34 1988 853-858
52. Shemin D. Elnour M. Amarantes B. Abuelo J.G. Oral estrogens decrease bleeding time and improve clinical bleeding in patients with renal failure American Journal of Medicine 89 1990 436-440
53. Sloand J.A. Schiff M.J. Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in anemia American Journal of Kidney Diseases 26 1995 22-26
54. Janson P.A. Jubelirer S.J. Weinstein M.J. Deykin D. Treatment of bleeding tendency in uremia with cryoprecipitate New England Journal of Medicine 303 1980 1318-1322
55. Levey A.S. Beto J.A. Coronado B.E. et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? American Journal of Kidney Diseases 32 1998 853-906
56. Parfrey P.S. Foley R.N. The clinical epidemiology of cardiac disease in chronic renal failure Journal of the American Society of Nephrology 10 1999 1606-1615
57. Kalantar-Zadeh K. Block G. Humphreys M.H. Kopple J.D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients Kidney International 63 2003 793-808
58. Manjunath G. Tighiourart H. Ibrahim H. et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community Journal of the American College of Cardiology 41 2003 47-55
59. Fried L.F. Shlipak M.G. Crump C. et al. Renal Insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals Journal of the American College of Cardiology 41 2003 1364-1372
60. Manjunath G. Tighiourart H. Coresh J. et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly Kidney International 63 2003 1121-1129
61. Browner W.S. Li J. Mangano D.T. In-hospital and long-term mortality in male veterans following noncardiac surgery Journal of the American Medical Association 268 1992 228-232
62. Swan S.K. Bennett W.M. Use of drugs in patients with renal failure In Schrier R.W. (Ed.) Diseases of the Kidney and Urinary Tract 7th edn 2001 3139-3186 Lippencott Williams and Wilkins Philadelphia
63. Olyaei A.J. de Mattos A.M. Bennett W.M. Prescribing drugs in renal disease In Brenner B.M. (Ed.) The Kidney 6th edn 2000 2606-2653 W.B. Saunders Philadelphia
64. Dreisbach A.W. Lertora J.J.L. The effect of chronic renal failure on hepatic drug metabolism and drug disposition Seminars in Dialysis 16 2003 45-50
65. Szeto H.H. Inturrisi C.E. Houde R. et al. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer Annals of Internal Medicine 86 1977 738-741
66. Hagmeyer K.O. Mauro L.S. Mauro V.F. Meperidine-related seizures associated with patient-controlled analgesia pumps Annals of Pharmacotherapy 27 1993 29-32
67. Chauvin M. Sandouk P. Scherrmann J.M. et al. Morphine pharmacokinetics in renal failure Anesthesiology 66 1987 327-331
68. Angst M.S. Buhrer M. Lotsch J. Insidious intoxication after morphine treatment in renal failure: delayed onset of morphine-6-glucuronide action Anesthesiology 92 2000 1473-1476
69. Ramzan M.I. Shanks C.A. Triggs E.J. Gallamine disposition in surgical patients with chronic renal failure British Journal of Clinical Pharmacology 12 1981 141-147
70. Brotherton W.P. Matteo R.S. Pharmacokinetics and pharmacodynamics of metocurine in humans with and without renal failure Anesthesiology 55 1981 273-276
71. McLeod K. Watson M.J. Rawlins M.D. Pharmacokinetics of pancuronium in patients with normal and impaired renal function British Journal of Anaesthesiology 48 1976 341-345
72. Matteo R.S. Nishitateno K. Pua E.K. Spector S. Pharmacokinetics of d-tubocurarine in man: effect of an osmotic diuretic on urinary excretion Anesthesiology 52 1980 335-338
73. Frampton J.E. McTavishc D. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia Drugs 45 1993 1066-1089
74. Mongin-Long D. Chabrol B. Baude C. et al. Atracurium in patients with renal failure. Clinical trial of a new neuromuscular blocker British Journal of Anaesthesia 58 supplement 1 1986 44S-48S